Status:
COMPLETED
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
Lead Sponsor:
Pfizer
Conditions:
Sleep Deprivation
Epilepsies, Partial
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the effects of pregabalin on sleep problems in patients with seizures.
Eligibility Criteria
Inclusion
- Partial epileptic seizures
- Not taking more than 1 background antiepileptic drug at study entry
- Disturbed sleep
Exclusion
- More than 1 secondarily generalized tonic/clonic seizure per week on average over the previous 3 months
- Medical, psychological, or social conditions that could interfere with normal sleep
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00643136
Start Date
November 1 2002
End Date
June 1 2004
Last Update
April 24 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Heeze, Netherlands, 5591 VE
2
Pfizer Investigational Site
The Hague, Netherlands, 2501 CK